Perflow Medical said today that it won CE Mark approval in the European Union for its Cascade Agile neurovascular net.

Netanya, Israel-based Perflow said the Cascade Agile non-occlusive remodeling net is designed to allow continuous blood flow during cerebral aneurysm repair and coiling.

“Multi-center clinical experience with the Cascade Net has been very positive to date. Our focus on providing physicians with more intra-operative control and better information to improve decision-making during complex neurovascular procedures has been well received by the market. And our nimble team continues to ideate and respond to unmet needs in the market, which led to developing the Cascade Agile,” CEO Danny Farin said in prepared remarks. “It is an exciting time, soon we will be publishing our clinical experience with the Stream and Cascade Net, which will fuel our future commercial expansion in and outside of Europe.”

Perflow brought in a $12 million funding round in February 2018.